BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18991707)

  • 1. Hypersensitivity to antineoplastic agents.
    Castells MC
    Curr Pharm Des; 2008; 14(27):2892-901. PubMed ID: 18991707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization for hypersensitivity reactions to medications.
    del Carmen Sancho M; Breslow R; Sloane D; Castells M
    Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.
    Caiado J; Castells MC
    Curr Allergy Asthma Rep; 2021 Jul; 21(6):37. PubMed ID: 34232411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
    Limsuwan T; Castells MC
    Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
    Castells M; Sancho-Serra Mdel C; Simarro M
    Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization.
    Breslow RG; Caiado J; Castells MC
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):155-60. PubMed ID: 19230468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
    Castells Guitart MC
    J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylaxis to chemotherapy and monoclonal antibodies.
    Castells MC
    Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy hypersensitivity reactions in ovarian cancer.
    Picard M; Matulonis UA; Castells M
    J Natl Compr Canc Netw; 2014 Mar; 12(3):389-402. PubMed ID: 24616544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.
    Sloane D; Govindarajulu U; Harrow-Mortelliti J; Barry W; Hsu FI; Hong D; Laidlaw T; Palis R; Legere H; Bunyavanich S; Breslow R; Wesemann D; Barrett N; Brennan P; Chong HJ; Liu A; Fernandez J; Fanning L; Kyin T; Cahill K; Bankova L; Lynch A; Berlin S; Campos S; Fuchs C; Mayer R; Matulonis U; Castells M
    J Allergy Clin Immunol Pract; 2016; 4(3):497-504. PubMed ID: 26895621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol.
    Pérez-Rodríguez E; Martínez-Tadeo JA; Pérez-Rodríguez N; Hernández-Santana G; Callero-Viera A; Rodríguez-Plata E; García-Robaina JC
    J Allergy Clin Immunol Pract; 2018; 6(5):1621-1627.e6. PubMed ID: 29361511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.